Preclinical CRO Market (By Service: Bioanalysis and DMPK Studies, Toxicology Testing, Others; By End-use: Biopharmaceutical Companies, Government and Academic Institutes, Medical Device Companies) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 20212030

Table of Contents

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics

5.1.1. Market Drivers

5.1.2. Market Restraints

5.1.3. Market Opportunities

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining power of suppliers

5.2.2. Bargaining power of buyers

5.2.3. Threat of substitute

5.2.4. Threat of new entrants

5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis

6.1.2. Key Strategies Adopted by Players

6.1.3. Vendor Landscape

6.1.3.1. List of Suppliers

6.1.3.2. List of Buyers

Chapter 7. Global Preclinical CRO Market, By Services

7.1. Preclinical CRO Market, by Services Type, 2020-2030

7.1.1. Bioanalysis and DMPK Studies

7.1.1.1. Market Revenue and Forecast (2016-2030)

7.1.2. Toxicology Testing

7.1.2.1. Market Revenue and Forecast (2016-2030)

7.1.3. Others

7.1.3.1. Market Revenue and Forecast (2016-2030)

Chapter 8. Global Preclinical CRO Market, By Application

8.1. Preclinical CRO Market, by Application, 2020-2030

8.1.1. Medical Device Companies

8.1.1.1. Market Revenue and Forecast (2016-2030)

8.1.2. Biopharmaceutical Companies

8.1.2.1. Market Revenue and Forecast (2016-2030)

8.1.3. Government and Academic Institutes

8.1.3.1. Market Revenue and Forecast (2016-2030)

Chapter 9. Global Preclinical CRO Market, Regional Estimates and Trend Forecast

9.1. North America

9.1.1. Market Revenue and Forecast, by Services (2016-2030)

9.1.2. Market Revenue and Forecast, by Application (2016-2030)

9.1.3. U.S.

9.1.3.1. Market Revenue and Forecast, by Services (2016-2030)

9.1.3.2. Market Revenue and Forecast, by Application (2016-2030)

9.1.4. Rest of North America

9.1.4.1. Market Revenue and Forecast, by Services (2016-2030)

9.1.4.2. Market Revenue and Forecast, by Application (2016-2030)

9.2. Europe

9.2.1. Market Revenue and Forecast, by Services (2016-2030)

9.2.2. Market Revenue and Forecast, by Application (2016-2030)

9.2.3. UK

9.2.3.1. Market Revenue and Forecast, by Services (2016-2030)

9.2.3.2. Market Revenue and Forecast, by Application (2016-2030)

9.2.4. Germany

9.2.4.1. Market Revenue and Forecast, by Services (2016-2030)

9.2.4.2. Market Revenue and Forecast, by Application (2016-2030)

9.2.5. France

9.2.5.1. Market Revenue and Forecast, by Services (2016-2030)

9.2.5.2. Market Revenue and Forecast, by Application (2016-2030)

9.2.6. Rest of Europe

9.2.6.1. Market Revenue and Forecast, by Services (2016-2030)

9.2.6.2. Market Revenue and Forecast, by Application (2016-2030)

9.3. APAC

9.3.1. Market Revenue and Forecast, by Services (2016-2030)

9.3.2. Market Revenue and Forecast, by Application (2016-2030)

9.3.3. India

9.3.3.1. Market Revenue and Forecast, by Services (2016-2030)

9.3.3.2. Market Revenue and Forecast, by Application (2016-2030)

9.3.4. China

9.3.4.1. Market Revenue and Forecast, by Services (2016-2030)

9.3.4.2. Market Revenue and Forecast, by Application (2016-2030)

9.3.5. Japan

9.3.5.1. Market Revenue and Forecast, by Services (2016-2030)

9.3.5.2. Market Revenue and Forecast, by Application (2016-2030)

9.3.6. Rest of APAC

9.3.6.1. Market Revenue and Forecast, by Services (2016-2030)

9.3.6.2. Market Revenue and Forecast, by Application (2016-2030)

9.4. MEA

9.4.1. Market Revenue and Forecast, by Services (2016-2030)

9.4.2. Market Revenue and Forecast, by Application (2016-2030)

9.4.3. GCC

9.4.3.1. Market Revenue and Forecast, by Services (2016-2030)

9.4.3.2. Market Revenue and Forecast, by Application (2016-2030)

9.4.4. North Africa

9.4.4.1. Market Revenue and Forecast, by Services (2016-2030)

9.4.4.2. Market Revenue and Forecast, by Application (2016-2030)

9.4.5. South Africa

9.4.5.1. Market Revenue and Forecast, by Services (2016-2030)

9.4.5.2. Market Revenue and Forecast, by Application (2016-2030)

9.4.6. Rest of MEA

9.4.6.1. Market Revenue and Forecast, by Services (2016-2030)

9.4.6.2. Market Revenue and Forecast, by Application (2016-2030)

9.5. Latin America

9.5.1. Market Revenue and Forecast, by Services (2016-2030)

9.5.2. Market Revenue and Forecast, by Application (2016-2030)

9.5.3. Brazil

9.5.3.1. Market Revenue and Forecast, by Services (2016-2030)

9.5.3.2. Market Revenue and Forecast, by Application (2016-2030)

9.5.4. Rest of LATAM

9.5.4.1. Market Revenue and Forecast, by Services (2016-2030)

9.5.4.2. Market Revenue and Forecast, by Application (2016-2030)

Chapter 10. Company Profiles

10.1. Envigo Corporation

10.1.1. Company Overview

10.1.2. Product Offerings

10.1.3. Financial Performance

10.1.4. Recent Initiatives

10.2. MPI research

10.2.1. Company Overview

10.2.2. Product Offerings

10.2.3. Financial Performance

10.2.4. Recent Initiatives

10.3. Eurofins Scientific

10.3.1. Company Overview

10.3.2. Product Offerings

10.3.3. Financial Performance

10.3.4. Recent Initiatives

10.4. PRA Health Sciences, Inc.

10.4.1. Company Overview

10.4.2. Product Offerings

10.4.3. Financial Performance

10.4.4. Recent Initiatives

10.5. Wuxi AppTec

10.5.1. Company Overview

10.5.2. Product Offerings

10.5.3. Financial Performance

10.5.4. Recent Initiatives

10.6. Medpace, Inc.

10.6.1. Company Overview

10.6.2. Product Offerings

10.6.3. Financial Performance

10.6.4. Recent Initiatives

10.7. Pharmaceutical Product Development (PPD), LLC

10.7.1. Company Overview

10.7.2. Product Offerings

10.7.3. Financial Performance

10.7.4. Recent Initiatives

10.8. PARAXEL International Corporation

10.8.1. Company Overview

10.8.2. Product Offerings

10.8.3. Financial Performance

10.8.4. Recent Initiatives

10.9. ICON Plc

10.9.1. Company Overview

10.9.2. Product Offerings

10.9.3. Financial Performance

10.9.4. Recent Initiatives

10.10. Laboratory Corporation of America, Inc.

10.10.1. Company Overview

10.10.2. Product Offerings

10.10.3. Financial Performance

10.10.4. Recent Initiatives

Chapter 11. Research Methodology

11.1. Primary Research

11.2. Secondary Research

11.3. Assumptions

Chapter 12. Appendix

12.1. About Us

12.2. Glossary of Terms